4
Changes in Ownership
BOSTON SCIENTIFIC CORP Filed Acc 0001225208-24-000107
EVP & Group Pres, Cardiology sold 81,940 shares at $57.50 ($4,711,550)
- EVP & Group Pres, Cardiology acquired 79,988 shares (option exercise)
- EVP & Group Pres, Cardiology gave up 10,908 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Fitzgerald Joseph Michael · EVP & Group Pres, Cardiology
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-29 | Exercise or conversion : show line 1 in the form | +58,189 | $16.31 | $949,063 | 256,181 | D |
| 2023-12-29 | Sale : show line 2 in the form | −81,940 | $57.50 | $4,711,550 | 174,241 | D |
| 2024-01-01 | Exercise or conversion : show line 3 in the form | +21,799 | 196,040 | D | ||
| 2024-01-01 | Shares withheld for taxes : show line 4 in the form | −10,908 | $57.81 | $630,591 | 185,132 | D |
| Open-market sales · 81,940 sh · avg $57.50 · $4,711,550 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-12-29 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −58,189 | 0 | D |
| 2024-01-01 | Exercise or conversion : show line 6 in the form Performance Share Units | −21,799 | 0 | D |
Loading xslF345X05/doc4.xml…